Literature DB >> 32106906

False Memories: The Other Side of Forgetting.

Katherine W Turk1,2, Rocco Palumbo1,2, Rebecca G Deason3, Anna Marin1,2, Ala'a Elshaar1,2, Emma Gosselin1,2,4, Maureen K O'Connor1,2,5, Yorghos Tripodis6, Andrew E Budson1,2.   

Abstract

OBJECTIVE: To measure caregivers' and clinicians' perception of false memories in the lives of patients with memory loss due to Alzheimer's disease (AD) and mild cognitive impairment (MCI) using a novel false memories questionnaire. Our hypotheses were that false memories are occurring as often as forgetting according to clinicians and family members.
METHOD: This prospective, questionnaire-based study consisting of 20 false memory questions paired with 20 forgetting questions had two forms: one for clinicians and the other for family members of older subjects. In total, 226 clinicians and 150 family members of 49 patients with AD, 44 patients with MCI, and 57 healthy older controls (OCs) completed the questionnaire.
RESULTS: False memories occurred nearly as often as forgetting according to clinicians and family members of patients with MCI and AD. Family members of OCs and patients with MCI reported fewer false memories compared to those of the AD group. As Mini-Mental State Examination scores decreased, the mean score increased for both forgetting and false memories. Among clinicians, correlations were observed between the dementia severity of patients seen with both forgetting and false memories questionnaire scores as well as with the impact of forgetting and false memories on daily life.
CONCLUSION: Patients with AD experience false memories almost as frequently as they do forgetting. Given how common false memories are in AD patients, additional work is needed to understand the clinical implications of these false memories on patients' daily lives. The novel false memories questionnaire developed may be a valuable tool.

Entities:  

Keywords:  Alzheimer’s disease; Dementia; Everyday function; Memory and surveys; Mild cognitive impairment

Mesh:

Year:  2020        PMID: 32106906      PMCID: PMC7319895          DOI: 10.1017/S1355617720000016

Source DB:  PubMed          Journal:  J Int Neuropsychol Soc        ISSN: 1355-6177            Impact factor:   2.892


  25 in total

Review 1.  Misunderstanding analysis of covariance.

Authors:  G A Miller; J P Chapman
Journal:  J Abnorm Psychol       Date:  2001-02

2.  The diagnosis of mild cognitive impairment due to Alzheimer's disease: recommendations from the National Institute on Aging-Alzheimer's Association workgroups on diagnostic guidelines for Alzheimer's disease.

Authors:  Marilyn S Albert; Steven T DeKosky; Dennis Dickson; Bruno Dubois; Howard H Feldman; Nick C Fox; Anthony Gamst; David M Holtzman; William J Jagust; Ronald C Petersen; Peter J Snyder; Maria C Carrillo; Bill Thies; Creighton H Phelps
Journal:  Alzheimers Dement       Date:  2011-04-21       Impact factor: 21.566

3.  The use of metacognitive strategies to decrease false memories in source monitoring in patients with mild cognitive impairment.

Authors:  Rebecca G Deason; Neil A Nadkarni; Michelle J Tat; Sean Flannery; Bruno Frustace; Brandon A Ally; Andrew E Budson
Journal:  Cortex       Date:  2017-02-03       Impact factor: 4.027

4.  Activities of daily living in Alzheimer's disease: neuropsychiatric, cognitive, and medical illness influences.

Authors:  S Tekin; L A Fairbanks; S O'Connor; S Rosenberg; J L Cummings
Journal:  Am J Geriatr Psychiatry       Date:  2001       Impact factor: 4.105

5.  Assessment of older people: self-maintaining and instrumental activities of daily living.

Authors:  M P Lawton; E M Brody
Journal:  Gerontologist       Date:  1969

Review 6.  Clinical features and pharmacologic treatment of behavioral symptoms of Alzheimer's disease.

Authors:  S Borson; M A Raskind
Journal:  Neurology       Date:  1997-05       Impact factor: 9.910

7.  Absence of a relationship between subjective memory complaint and objective memory impairment in mild cognitive impairment (MCI): is it time to abandon subjective memory complaint as an MCI diagnostic criterion?

Authors:  Megan Elizabeth Lenehan; Shannon Zofia Klekociuk; Mathew James Summers
Journal:  Int Psychogeriatr       Date:  2012-05-01       Impact factor: 3.878

8.  Neuropsychological signs of Alzheimer's disease 8 years prior to diagnosis.

Authors:  Nicole S Schmid; Kirsten I Taylor; Nancy S Foldi; Manfred Berres; Andreas U Monsch
Journal:  J Alzheimers Dis       Date:  2013       Impact factor: 4.472

9.  Subjective memory complaints and objective memory impairment in the Vienna-Transdanube aging community.

Authors:  Susanne Jungwirth; Peter Fischer; Silvia Weissgram; Walter Kirchmeyr; Peter Bauer; Karl-Heinz Tragl
Journal:  J Am Geriatr Soc       Date:  2004-02       Impact factor: 5.562

10.  False recognition correlates with amyloid-beta (1-42) but not with total tau in cerebrospinal fluid of patients with dementia and mild cognitive impairment.

Authors:  Helmut Hildebrandt; Andreas Haldenwanger; Paul Eling
Journal:  J Alzheimers Dis       Date:  2009       Impact factor: 4.472

View more
  3 in total

1.  The Effectiveness of Item-Specific Encoding and Conservative Responding to Reduce False Memories in Patients with Mild Cognitive Impairment and Mild Alzheimer's Disease Dementia.

Authors:  Christopher Malone; Katherine W Turk; Rocco Palumbo; Andrew E Budson
Journal:  J Int Neuropsychol Soc       Date:  2020-08-10       Impact factor: 2.892

2.  Measuring global functioning in older adults with cognitive impairments using the Rasch model.

Authors:  Rocco Palumbo; Alberto Di Domenico; Federica Piras; Salvatore Bazzano; Mario Zerilli; Fabio Lorico; Erika Borella
Journal:  BMC Geriatr       Date:  2020-11-23       Impact factor: 3.921

3.  Home-Based Electronic Cognitive Therapy in Patients With Alzheimer Disease: Feasibility Randomized Controlled Trial.

Authors:  Anna Marin; Renée DeCaro; Kylie Schiloski; Ala'a Elshaar; Brigid Dwyer; Ana Vives-Rodriguez; Rocco Palumbo; Katherine Turk; Andrew Budson
Journal:  JMIR Form Res       Date:  2022-09-12
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.